NIOX Group Plc (CSSPF)
OTCMKTS
· Delayed Price · Currency is USD
0.6900
0.00 (0.00%)
At close: Apr 11, 2025
NIOX Group Revenue
In the year 2024, NIOX Group had annual revenue of 41.80M GBP with 13.59% growth.
Revenue
41.80M GBP
Revenue Growth
+17.09%
P/S Ratio
6.21
Revenue / Employee
459.34K GBP
Employees
91
Market Cap
325.03M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |